损及肾盂行锁边缝合法的中华田园犬实验研究

Abstract
Figure/Table
References (20)
Related Citation (1)

Download: PDF (800 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of continuous suture of renal pelvis, renal parenchyma and renal capsule on wound suture after removal of renal pelvis tumor. Methods Four healthy male Chinese rural dogs were selected. After successful anesthesia, the operation was performed according to the human open kidney partial resection procedure. The sutures of the renal pelvis mucosa, submucosa, muscular layer and renal layer were sutured continuously. The operation time, intraoperative blood loss, arterial block time, postoperative recovery time, and perioperative complications were observed. Results The operation time of renal artery occlusion, local occlusion time, renal artery occlusion time and local occlusion time were (39.00±2.16), (37.50±4.30), (10.25±2.50), (8.45±1.81) min, respectively. The amount of bleeding in the renal artery block partial nephrectomy and suture was (54.50±4.21) mL, and the amount of hemorrhage during local partial nephrectomy and suturing was (57.50±9.58) mL. After the anesthesia waken up, they could move in place. The next day, they were given food and returned to normal after a week. Conclusion The operation time is short, the amount of bleeding is small, the recovery is fast, and there are no serious complications such as major bleeding and urinary leakage after operation. It effectively prevents and eliminates two common complications after partial nephrectomy, which lays a foundation for its clinical application.

Key words： Partial nephrectomy Renal pelvic tumors Lockstitch method Block

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Gao1
	2 FU Dian3 CHENG Wen3

Cite this article:

LIU Gao1,2 FU Dian3 CHENG Wen3. Experimental animal study of injury and kidney pelvis line suture in Chinese rural dogs[J]. 中国医药导报, 2018, 15(32): 9-12.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2018/V15/I32/9

[1] Basma G，Tim E. Medical treatment of renal cancer：new horizons [J]. Br J Cancer，2016，115（5）：505-516.
[2] Huang WC，Atoria CL，Bjurlin M，et al. Management of small kidney cancers in the new millennium：contemporary trends and outcomes in a population-based cohort [J]. JAMA Sur，2016，150（7）：664.
[3] Laguna MP. Re：management of small renal masses：American society of clinical oncology clinical practice guideline [J]. J Urol，2017，198（3）：480-482.
[4] Smith ZL. Current status of minimally invasive surgery for renal cell carcinoma [J]. Curr Urol Rep，2016，17（6）：1-7.
[5] Boulière F，Crepel M，Bigot P，et al. Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm [J]. Prog Urol，2011，21（12）：842-850.
[6] 马潞林，邓绍晖.腹腔镜肾部分切除术相关热点研究进展[J].现代泌尿外科杂志，2016，21（3）：161-163.
[7] Fossati N，Larcher A，Gadda GM，et al. Minimally invasive partial nephrectomy versus laparoscopic cryoablation for patients newly diagnosed with a single small renal mass [J]. Eur Urol Focus，2015，1（1）：66-72.
[8] Rimar K，Khambati A，Mcguire BB，et al. Radiofrequency ablation-assisted zero-ischemia robotic laparoscopic partial nephrectomy：oncologic and functional outcomes in 49 patients [J]. Adv Urol，2016，2016：8 045 210.
[9] Cordeiro ER，Barwari K，Anastasiadis A，et al. Laparoscopic cryotherapy for small renal masses：current state [J]. Arch Esp Urol，2013，66（1）：41-53.
[10] Ruan Y，Wang XH，Wang K，et al. Clinical evaluation and technical features of three-dimensional laparoscopic partial nephrectomy with selective segmental artery clamping [J]. World J Urol，2016，34（5）：679-685.
[11] Canter DJ，Cahn DB，Uzzo RG. Surgical approaches to early-stage renal cell carcinoma [M]. Springer International Publishing，2015.
[12] Hugosson J，Aus G，Becker C，et al. Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden [J]. Bju Int，2015，85（9）：1078-1084.
[13] Tosoian JJ，Carter HB，Lepor A，et al. Active surveillance for prostate cancer：current evidence and contemporary state of practice [J]. Nat Rev Urol，2016，13（4）：205-215.
[14] King CR，Brooks JD，Gill H，et al. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer [J]. Int J Radiat Oncol Biol Phys，2012，82（2）：877-882.
[15] Horwitz MD，Hanbury DC，King CM. Renal artery pseudoaneurysm following partial nephrectomy treated with stent-graft [J]. Br J Radiol，2014，78（926）：161-163.
[16] Sood A，Abdollah F，Sammon JD，et al. An evaluation of the timing of surgical complications following nephrectomy：data from the American College of Surgeons National Surgical Quality Improvement Program （ACS-NSQIP） [J]. World J Urol，2015，33（12）：2031-2038.
[17] Mijugkovi■ M，Stanojevi■ I，Milovi■ N，et al. Urinary KIM-1 and AQP-1 in patients with clear renal cell carcinoma：potential noninvasive biomarkers [J]. Vojnosanit Pregl，2016，73（3）：266.
[18] Enrico B，Giuseppe B，Giuseppina N，et al. What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment [J]. Oncotarget，2015，6（34）：35 589-35 601.
[19] Rey JB，Launay-Vacher V，Tournigand C. Regorafenib as a single-agent in the treatment of patients with gastrointestinal tumors：an overview for pharmacists [J]. Target Oncol，2015，10（2）：199-213.
[20] Kumamoto K，Endo S，Isohata N，et al. Pseudocirrhosis caused by regorafenib in an advanced rectal cancer patient with multiple liver metastases [J]. Mol Clin Oncol，2017，6（1）：63-66.